70 related articles for article (PubMed ID: 7947633)
1. Overexpression of heat shock protein (hsp) 70 associated with abnormal p53 expression in cancer of the pancreas.
Lee CS; Montebello J; Rush M; Georgiou T; Wawryk S; Rode J
Zentralbl Pathol; 1994 Aug; 140(3):259-64. PubMed ID: 7947633
[TBL] [Abstract][Full Text] [Related]
2. Expression of heat shock proteins in chronic pancreatitis: protective or pathogenic roles?
Slater S; Jalleh R; Gilbertson J; Lampert I; Williamson R; Foster CS
Lab Invest; 1997 Apr; 76(4):533-45. PubMed ID: 9111515
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers.
Lee CS; Charalambous D
Zentralbl Pathol; 1994 Aug; 140(3):271-5. PubMed ID: 7947635
[TBL] [Abstract][Full Text] [Related]
4. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
Selkirk JK; Merrick BA; Stackhouse BL; He C
Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
[TBL] [Abstract][Full Text] [Related]
5. Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues.
Iwaya K; Tsuda H; Fujita S; Suzuki M; Hirohashi S
Lab Invest; 1995 Jun; 72(6):707-14. PubMed ID: 7540234
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
7. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
8. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.
Zhang SY; Ruggeri B; Agarwal P; Sorling AF; Obara T; Ura H; Namiki M; Klein-Szanto AJ
Arch Pathol Lab Med; 1994 Feb; 118(2):150-4. PubMed ID: 8311654
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of heat shock proteins in pancreatic carcinoma.
Gress TM; Müller-Pillasch F; Weber C; Lerch MM; Friess H; Büchler M; Beger HG; Adler G
Cancer Res; 1994 Jan; 54(2):547-51. PubMed ID: 8275493
[TBL] [Abstract][Full Text] [Related]
11. Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.
Mäkinen K; Loimas S; Hakala T; Eskelinen M
Anticancer Res; 2007; 27(1A):23-6. PubMed ID: 17352211
[TBL] [Abstract][Full Text] [Related]
12. P53 and heat shock protein 70 expressions in colorectal adenocarcinoma.
Shotar AM
Saudi Med J; 2005 Oct; 26(10):1602-6. PubMed ID: 16228064
[TBL] [Abstract][Full Text] [Related]
13. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical localization of p53 protein in smoking patients with chronic pancreatitis].
Sliwińska-Mossoń M; Milnerowicz H; Milnerowicz S; Rabczyński J
Przegl Lek; 2006; 63(10):941-5. PubMed ID: 17288189
[TBL] [Abstract][Full Text] [Related]
15. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.
Vargas-Roig LM; Fanelli MA; López LA; Gago FE; Tello O; Aznar JC; Ciocca DR
Cancer Detect Prev; 1997; 21(5):441-51. PubMed ID: 9307847
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic adenocarcinomas frequently show p53 gene mutations.
Scarpa A; Capelli P; Mukai K; Zamboni G; Oda T; Iacono C; Hirohashi S
Am J Pathol; 1993 May; 142(5):1534-43. PubMed ID: 8494051
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
18. p53 protein expression as prognostic factor in human pancreatic cancer.
Sato Y; Nio Y; Song MM; Sumi S; Hirahara N; Minari Y; Tamura K
Anticancer Res; 1997; 17(4A):2779-88. PubMed ID: 9252715
[TBL] [Abstract][Full Text] [Related]
19. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
Tomaszewska R; Nowak K; Stachura J
Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
[TBL] [Abstract][Full Text] [Related]
20. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
Elledge RM; Clark GM; Fuqua SA; Yu YY; Allred DC
Cancer Res; 1994 Jul; 54(14):3752-7. PubMed ID: 8033095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
